TrialJournal of the National Cancer Institute2017
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Julien Taieb et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
161 papers cite itlatest 60 shown
this paperpooled ittrialcites it